Lacaba, Jennifer L.
HRN: 15-67-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2024
BENZYL PENICILLIN 1MU (VIAL)
05/11/2024
05/11/2024
IM
1g
Every 3 Weeks
Rheumatic Heart Disease
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes